Kidney Disease

HSCI scientists recognized for “High-Risk, High-Reward” research

October 3, 2019

Two HSCI researchers will receive the National Institutes of Health (NIH) Director's New Innovator Award. Jason Buenrostro, Ph.D. and Ryuji Morizane, M.D., Ph.D. have been recognized for their highly innovative biomedical research that has transformative potential.

“Each year, I look forward to seeing the creative approaches these researchers take to solve tough problems in biomedical and behavioral research,” said NIH Director Francis S. Collins in the award...

Read more about HSCI scientists recognized for “High-Risk, High-Reward” research

Researchers identify first blood biomarker for progressive kidney disease

July 2, 2014

FDA-approval required before clinical use

A new blood test has the potential to reveal whether a person recently diagnosed with type 1 diabetes is already at risk for kidney failure—information that might allow physicians to alter the course of treatment and slow disease progression.

This is the hope of Harvard Stem Cell Institute (HSCI) scientists at Brigham and Women’s Hospital who recently demonstrated that a laboratory test could detect, in the blood of mice and humans, the...

Read more about Researchers identify first blood biomarker for progressive kidney disease

Kidney injury molecule linked to chronic kidney disease

October 2, 2013

More than 15 years after the discovery of kidney injury molecule-1 (KIM-1) by Joseph Bonventre, MD, PhD, researchers in the HSCI Kidney Disease Program—of which Bonventre is a member—have found that the molecule promotes the scar tissue formation typically associated with chronic kidney disease, which affects approximately 9-10 percent of the world’s population. The finding was made in mice.... Read more about Kidney injury molecule linked to chronic kidney disease